Skip to main content
. 2012 Dec 7;18(45):6614–6619. doi: 10.3748/wjg.v18.i45.6614

Table 2.

Characteristics of the 978 patients with polyps n (%)

Period A (1989-1993) 273 patients Period B (2003-2007) 705 patients P value
Male 178 (65.2) 418 (59.3) 0.0892
Female 95 (34.8) 287 (40.7)
Age (yr)
< 50 50 (19.2) 91 (12.9) < 0.0015
50-59 44 (16.9) 154 (21.9)
60-69 103 (39.5) 226 (32.1)
70-79 57 (21.8) 185 (26.3)
≥ 80 7 (2.7) 48 (6.8)
Total No. of polyps 428 1265
No. of polyps, mean ± SD 1.6 ± 1 1.8 ± 1.3 0.0102
No. of polyps, median 1 1
Range 1-6 1-14
Dimensions
< 5 mm 114 (26.6) 530 (41.9) < 0.00005
5-9 mm 228 (53.3) 454 (35.9)
10-19 mm 44 (10.3) 191 (15.1)
20-29 mm 23 (5.4) 52 (4.1)
30-39 mm 9 (2.1) 25 (2)
40+ mm 10 (2.3) 13 (1)
Histopathological pattern
Hyperplastic 91 (33.6) 438 (38.7) < 0.00005
Mild/moderate dispalsia1 151 (55.7) 597 (52.7)
Severe dysplasia2 27 (10) 87 (7.7)
Others3 2 (0.7) 10 (0.9)
1

Tubular, mixed or villous adenoma with mild or low grade dysplasia;

2

Tubular, mixed or villous adenoma with severe dysplasia or cancer in situ or serrated adenoma;

3

Lymphatic lump, hamartoma, leiomyoma, anal human papilloma virus.